Genotoxicity evaluation of graphene derivatives by a battery of in vitro assays.

Chem Biol Interact

Area of Toxicology, Faculty of Pharmacy, Universidad de Sevilla, Professor García González n°2, 41012, Seville, Spain.

Published: February 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The interest of graphene materials has increased markedly in the recent years for their promising applications in many fields as food packing. These new applications have caused some concern regarding their safety for consumers since the intake of these materials may increase. In this sense, a battery of in vitro test is required before its use as a food contact material. Then, the aim of this study was to assess the potential mutagenicity and genotoxicity of graphene oxide (GO) and reduced-graphene oxide (rGO) following the recommendations of the European Food Safety Authority (EFSA). Thus, the mouse lymphoma assay (MLA) and the micronucleus test (MN) were performed in L5178YTk ± cells, and the Caco-2 cells were used for the standard and modified comet assays. The results indicated that GO (0-250 μg/mL) was not mutagenic in the MLA. However, rGO revealed mutagenic activity from 250 μg/mL and 125 μg/mL after 4h and 24h of exposure, respectively. In the MN test, negative results were obtained for both compounds at the concentrations assayed (0-250 μg/mL) for GO/rGO. Moreover, no DNA strand breaks, or oxidative DNA damage were detected in Caco-2 cells exposed to GO (0-250 μg/mL) and rGO (0-176.3 μg/mL for 24h and 0-166.5 μg/mL for 48h). Considering the mutagenic potential of rGO observed further investigation is needed to describe its toxic profile.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cbi.2023.110367DOI Listing

Publication Analysis

Top Keywords

battery vitro
8
genotoxicity evaluation
4
evaluation graphene
4
graphene derivatives
4
derivatives battery
4
vitro assays
4
assays interest
4
interest graphene
4
graphene materials
4
materials increased
4

Similar Publications

Objective: Introduced in 1970s, Spinal Cord Stimulator (SCS) devices have played a crucial role in managing a wide range of complex and refractory chronic pain, particularly back/leg pain as well as neuropathic pain. Currently, two primary types of leads, cylindrical and paddle leads, are prevalent in pain management. While both effectively alleviate pain, cylindrical leads, due to their small size, are susceptible to movement and migration as well as a smaller surface area for coverage, leading to device displacement and failure to provide pain relief.

View Article and Find Full Text PDF

Collaborative research between the US EPA, European research institutes, and the OECD has resulted in a developmental neurotoxicity in vitro testing battery (DNT-IVB) that assesses multiple biological processes that are critical for neurodevelopment. The DNT-IVB was developed to address the large number of chemicals that have not been tested in time- and resource-intensive in vivo DNT guideline studies. In keeping with recommendations that the DNT-IVB should evolve with the science, this work has taken two 96-well DNT-IVB assays that independently measure human neural progenitor cell proliferation or apoptosis and combined them into a multiplexed, 384-well assay that simultaneously measures proliferation, apoptosis, and cell viability.

View Article and Find Full Text PDF

Acne is a common skin condition caused by the blockage of hair follicles, which is often associated with adolescents. Beyond physical discomfort and potential scarring, acne can also result in mental health issues including low self-esteem and anxiety. Among all available medical treatments, topical antibiotics are effective for acne treatment due to their rapid action, anti-inflammatory properties, minimal side effects, and accessibility.

View Article and Find Full Text PDF

A broad range of anthropogenic chemicals have been reported to display estrogenic (ER) or antiandrogenic bioactivity using high throughput screening (HTS) in vitro assays. Some regulatory agencies have developed tiered in vitro - in vivo endocrine screening batteries in which positive in vitro results automatically "trigger" studies with laboratory animals. Since in vitro assays can produce a number of false positive and false negative results, automatically triggering in vivo testing could result in the unnecessary use of animals and other resources.

View Article and Find Full Text PDF

This editorial prefaces the annual themed issue on those methods with application to safety pharmacology (SP) in the Journal of Pharmacological and Toxicological Methods (JPTM). Highlighted content is derived from the 2024 Safety Pharmacology Society (SPS) meeting held in San Diego, CA, USA. The meeting showcased 122 posters, many of which are reproduced as abstracts published in JPTM.

View Article and Find Full Text PDF